Physician profile
Oriente Esposo
NPI 1437262474
$1,144.07
in general payments reported to CMS, 2019-2025
9 companies · $25.03 in 2025
The $25.03 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $290 · 2020: $72.53 · 2021: $279 · 2022: $240 · 2023: $162 · 2024: $75.44 · 2025: $25.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $262.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $262.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $506.04 | 2020-2025 | Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $181.11 | 2019-2022 | |
| Novo Nordisk INC | $133.44 | 2019-2023 | |
| Amgen INC. | $131.58 | 2019 | |
| Merck Sharp & Dohme LLC | $100.00 | 2019 | |
| Abbott Laboratories | $36.49 | 2023 | Freestyle Libre 3 |
| Eisai INC. | $24.55 | 2020 | |
| Agile Therapeutics, INC. | $16.47 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $14.39 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Oriente Esposo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.